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Abstract

Men and women differ in their use and response to methamphetamine. Compared to men,
women initiate use of methamphetamine at an earlier age, become regular users faster, and use it
for a different purpose, such as weight loss. While numerous studies have used rodent models to
understand the cellular basis of addiction, the majority of these studies have been conducted in
adult male animals. We used a conditioned place preference paradigm to investigate the
rewarding effects of methamphetamine (1 mg/kg) in male and female mice of two different
strains, C57Bl/6 and 129/SvEv. Given that substance abuse is often initiated in humans during
adolescence, our experiments began during this developmental time period (postnatal day 41).
We found that methamphetamine induced conditioned place preference in adolescent female
C57Bl/6 mice but not adolescent female 129/SvEv mice. Conversely, methamphetamine
induced conditioned place preference in adolescent male 129/SvEv mice, but not adolescent
male C57Bl/6 mice. Methamphetamine significantly enhanced locomotor activity in all sexes
and strains tested, but only female and male 129/SvEv mice showed sensitization. These results
indicate both strain and sex differences in the rewarding effects of methamphetamine in
adolescent mice.
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Methamphetamine-Induced Conditioned Place Preference In Adolescent Male and Female
Mice of Two Strains
Addiction to methamphetamine is a serious public health issue, (Gonzales, Mooney &
Rawson, 2010; Maxwell & Rutkowski, 2008), with approximately 133,000 new users of this
drug each year, resulting in an annual cost of $23.4 billion to the United States (Gonzales,
Mooney & Rawson 2010; Zuloaga, et al., 2014). Interestingly, there are several differences
between men and women in their use of and response to methamphetamine (reviewed in Dluzen
& Liu, 2008). Women begin using methamphetamine earlier than men, are younger when they
first enter treatment programs (Hser et al., 2005; Lin et al., 2004), and have a shorter transition
from initial use to regular use (Rawson, Gonzales, Obert, McCann, & Brethen, 2005). While
both men and women often use more than one substance of abuse, more women than men report
methamphetamine as their main drug of choice (Cretzmeyer, Sarrazin, Huber, Block, & Hall,
2003; Polcin, Buscemi, Nayak, Korcha, & Galloway, 2012).
Despite this sex difference in drug taking behavior, research involving animal models has
primarily used male rodents to understand the genetic and cellular basis of addiction (Buck &
Siegel 2015; for review, see Fattore, Altea, & Fratta, 2008; Zakharaova, Wade, & Izenwasser,
2009). In addition, these studies are often conducted in adult animals, even though substance
abuse is most frequently initiated during adolescence (Schramm-Sapyta, Walker, Caster, Levin,
& Kuhn, 2009). In the present study, we investigated the rewarding effects of methamphetamine
in adolescent male and female mice of two strains, C57Bl/6 and 129/SvEv, using the conditioned
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place preference paradigm. Conditioned place preference is a commonly used test for
investigating the rewarding effects of drugs of abuse in rodents (for review, see Tzschentke,
1998) and involves training animals to associate the drug-induced state with one side of the
conditioning chamber. Given that both strains are commonly used background strains for
creating transgenic mice, the goal of this work is to provide insight into which strain would be
appropriate for future work involving selective manipulation of proteins in the brain.
Method
Animals
Male and female C57Bl/6 and 129/SvEv mice (Taconic Biosciences, Germantown, NY)
were shipped to the Hunter College Animal Facility at postnatal day (PND) 21. Mice were
group-housed 4 per cage and kept on a 5am/5pm, 12-h light/dark cycle with food and water
available ad libitum. Experimental procedures began on PND 38 (middle adolescence) and all
testing occurred during a portion of the light cycle (10am - 4pm). Each sex was tested
separately. Experimental procedures were conducted in accordance with the Institutional Animal
Care and Use Committee (IACUC) of Hunter College, CUNY and in accordance with the NIH
Guide for the Care and Use of Laboratory Animals.
Drug
Methamphetamine hydrochloride was purchased from Sigma-Aldrich (St. Louis, MO,
USA) and dissolved in sterile saline (0.9%). On each day of drug administration,
methamphetamine was made fresh prior to being injected intraperatoneally (i.p.) at a dose of
1mg/kg.
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Apparatus
Conditioned place preference was conducted in a three-compartment apparatus
(Columbus Instruments, Columbus, OH). One compartment contained white Plexiglas walls and
floors and was scented with orange Clorox wipes (light side). The other compartment had black
walls and a red floor that was textured with strips of white tape and was scented with 100%
ethanol (dark side). A removable divider was used to separate the light and dark compartments.
The third compartment was a clear holding chamber that provided access to both the light and
dark compartments when the adjoining door was opened. Prior to each trial, the holding
chamber was wiped down with a wet paper towel and the light and dark chambers were wiped
down with their respective scents. The light and dark compartments were each 8.25” long, 12”
high and 12” wide. The holding chamber was 3.5” long x 3.5” wide x 5” deep.
Procedure
At the start of each session, all mice were weighed and given a distinct tail marking with
a Sharpie pen for identification purposes. There were four phases of the conditioned place
preference procedure: handling (days 1 and 2), preconditioning (day 3), conditioning (days 411), and postconditioning (day 12). Handling occurred on PNDs 38 and 39 and involved gently
holding the mouse by the tail for 2 minutes while it walked freely on the experimenter’s gloved
hand and sleeve. During preconditioning (PND 40), each mouse was allowed to freely explore
the light and dark compartments for 30 minutes. Place conditioning took place on the
subsequent 8 days (PND 41-48). On days 4, 6, 8, and 10, all mice received either
methamphetamine (drug group) or saline (saline group) before being confined to the light
compartment for 30 minutes. On days 5, 7, 9, and 11, all mice in both groups were injected with
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saline prior to being confined to the dark compartment for 30 minutes. During the
postconditioning test (PND 49), all mice had free access to the light and dark compartments for
30 minutes and preference was tested. Animals were not injected with drug or saline during the
postconditioning test.
Statistical Analysis
Cameras mounted above the conditioned place preference apparatus recorded behavior
during preconditioning, the first and last days drug was administered (conditioning sessions 1
and 7), and postconditioning. Videos were analyzed using ANY-maze software (Stoelting,
Wood Dale, IL) to determine time spent on each side of the conditioned place preference box
and locomotor activity in each compartment. Preference was determined by calculating the
difference between the amount of time spent in the drug-paired compartment (light chamber)
during postconditioning minus the amount of time spent in that compartment (light chamber)
during preconditioning (CPP score). A two-way ANOVA was used to analyze behavior during
preconditioning and to compare methamphetamine-induced locomotor activity across strains.
Tukey HSD was used for post-hoc analyses. For each sex and strain, a repeated-measures
ANOVA was used to evaluate the effects of drug and saline on locomotor activity following the
first (first injection) and last (fourth injection) exposure to methamphetamine. Student’s t test
was used to compare CPP scores of methamphetamine-treated and saline-treated groups.
Results
Conditioned Placed Preference in Female Mice
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For time spent in each side of the CPP box during preconditioning, the two-way ANOVA
revealed a significant main effect of compartment (F(1,157) = 366.19, p < 0.01) and strain ×
compartment interaction (F(1,57) = 139.7176, p < 0.01). Post-hoc tests showed that female
C57Bl/6 mice spent significantly more time in the dark compartment (𝑥= 1094.18 seconds) than
the light compartment (𝑥= 697.52 second) (p < 0.05). Similarly, female 129/SvEv mice spent
more time in the dark compartment (𝑥= 1739.17 seconds) than the light compartment (𝑥= 59.58
seconds) prior to treatment with drug or saline (p < 0.05). There was no main effect of strain
(F(1,157) = 0.0030 p = 0.9567), indicating that both C57Bl/6 and 129/SvEv female showed an
innate preference for the dark compartment. Therefore, drug was paired with the light
compartment, so that increases in time spent on the drug-paired side could be detected (Figure
1).
For female C57Bl/6 mice, methamphetamine significantly increased locomotor activity.
The repeated-measures ANOVA revealed a significant main effect of treatment (F(1,43) =
49.380, p < 0.01), but no significant main effect of injection day (F(1,43) = 3.3649, p = 0.0735)
and no significant treatment × injection day interaction (F(1,43) = .4353, p = 0.5129). These
results indicate that methamphetamine increased locomotor activity at both time points and there
was no drug sensitization effect (Figure 2).
Methamphetamine also significantly increased locomotor activity in female 129/SvEv
mice. The repeated-measures ANOVA revealed a significant main effect of treatment (F(1,30) =
15.885, p < 0.01), but no significant main effect of injection day (F(1,30) =.0123, p < 0.912) and
no treatment × injection day interaction (F(1,30) = 1.1766, p = 1.1766). These results indicate that
methamphetamine increased locomotor activity at both time points (Figure 3).
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To compare the effects of methamphetamine on locomotor activity across strains,
movement of each drug-treated female was calculated as a percentage of the respective salinetreated control group and averaged. The repeated-measures ANOVA revealed a significant main
effect of strain (F(1,35) = 13.341, p < 0.001), injection day (F(1,35) = 6.1440, p < 0.01), and strain ×
injection day interaction (F(1,35) = 4.488, p = 0.041). A two-way ANOVA confirmed these
results. Post-hoc tests revealed no significant difference between 129/SvEv and C57Bl/6 mice in
locomotor activity in response to the first drug injection (p > 0.05). However, 129/SvEv mice did
exhibit significantly more locomotor activity than C57Bl/6 mice in response to the fourth drug
injection (p < 0.05). Furthermore, within the 129/SvEv strain, mice showed significantly more
locomotor activity in response to the fourth than the first injection of drug, suggestive of drug
sensitization (Figure 4).
A CPP score was calculated to determine the rewarding effects of methamphetamine
during the postconditioning session. We found that the CPP score for drug-treated and salinetreated C57Bl/6 mice was significantly different (t(29) = 2.51, p < .001) (Figure 5), indicating
methamphetamine-induced conditioned place preference in that strain. In contrast, there was no
significant difference between drug-treated and saline-treated 129/SvEv mice (t(29) = 1.77, p =
0.08), indicating that this strain did not demonstrate methamphetamine-induced conditioned
place preference (Figure 6).
Conditioned Placed Preference in Male Mice
A two-way ANOVA was used to compare time spent in each side of the CPP box prior to
any treatment and revealed a significant main effect of compartment (F(1,90) = 3174.336, p <
0.0001), and strain × compartment interaction (F(1,90) = 188.6308, p < 0.05). Post-hoc tests
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revealed that C57Bl/6 mice spent significantly more time in the dark compartment (𝑥=1411.50
seconds) than the light compartment (𝑥= 388.49 seconds) (p < 0.05). Similarly, 129/SvEv mice
spent more time in the dark compartment (𝑥= 1743.50 seconds) than the light compartment (𝑥=
56.49 seconds) during preconditioning (p < 0.05). There was no significant main effect of strain
(F(1,90) = 0, p = 1.00), indicating that both male C57Bl/6 and 129/SvEv mice had an innate
preference for the dark compartment. Drug was therefore paired on the light side, so that
increases in time spent on the drug-paired side could be detected and testing conditions were the
same as those used in the females (Figure 7).
For male C57Bl/6 mice, methamphetamine increased locomotor activity following the
first and fourth injection of drug. The repeated-measures ANOVA revealed a significant main
effect of treatment (F(1,22) = 13.65, p < 0.001), but no significant main effect of injection day
(F(1,22) = 2.4941, p = 0.1285) and no treatment × injection day interaction (F(1,22) = .0005, p =
0.9831), indicating lack of drug sensitization (Figure 8).
Methamphetamine also increased locomotor activity in male 129/SvEv mice during the
first and fourth injection of meth. A repeated-measures ANOVA revealed a significant main
effect of treatment (F(1,22) = 21.725, p < 0.0001)and a treatment × injection day interaction
(F(1,22) = 5.1308, p =.0337), but no main effect of injection day (F(1,22) = 2.0788, p = 0.1634).
These results were confirmed with a two-way ANOVA. Post-hoc tests indicated that compared
to saline-treated controls, methamphetamine significantly increased locomotor activity following
the fourth injection (p < 0.05), but not the first injection of drug, indicating drug sensitization.
However, locomotor activity following the first and fourth injection of methamphetamine was
not significantly different (Figure 9).
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We compared the effects of methamphetamine on locomotor activity across strains using
a repeated-measures ANOVA. We found a significant main effect of strain (F(1,22) = 14.9370, p <
0.001), injection day (F(1,22) = 8.8459, p < 0.001), and strain × injection day interaction (F(1,22) =
9.3134, p < 0.01). A two-way ANOVA confirmed these results. Post-hoc tests revealed that
methamphetamine-induced locomotor activity was significantly higher in 129/SvEv mice
following the fourth injection than the first injection (p < 0.05). Furthermore, methamphetamine
increased locomotor activity significantly more in 129/SvEv mice than C57Bl/6 mice following
the fourth (p < 0.05) but not the first injection (Figure 10).
During postconditioning, the CPP score for drug-treated and saline-treated C57Bl/6 male
mice was not significantly different (t(22) = 0.23, p =0.81), indicating a lack of meth-induced
conditioned place preference (Figure 11). In contrast, the CPP score for drug-treated and salinetreated 129/SvEv mice were significantly different (t(21) = 2.74, p < 0.01) indicating that
methamphetamine-induced conditioned place preference in that strain (Figure 12).
Discussion
Despite known sex differences in the use of methamphetamine, the vast majority of
animal studies investigating the behavioral effects of this drug have used male rodents (Buck &
Siegel 2015). Furthermore, this line of research is typically conducted in adult animals, even
though drug use is most often initiated during adolescence (Schramm-Sapyta, Walker, Caster,
Levin, & Kuhn, 2009). To the best of our knowledge, this is the first study to investigate the
rewarding effects of methamphetamine in both male and female mice of two strains during
adolescence. Our results reveal that methamphetamine (1mg/kg) induced conditioned place
preference in adolescent female C57Bl/6 mice but not female 129/SvEv mice. Conversely,
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methamphetamine induced conditioned place preference in adolescent male 129/SvEv mice, but
not male C57Bl/6 mice. In contrast to our findings, previous studies report that male C57Bl/6
mice tested during late adolescence display conditioned place preference to amphetamine (2
mg/kg) and cocaine (2.5, 5 and 10 mg/kg) (Belzung, & Barreau, 2000) and adult male 129SvJ
mice do not exhibit conditioned place preference to cocaine (5 and 10 mg/kg) (Miner, 1997).
This discrepancy might be explained by differences in the drugs of abuse that were tested, the
exact substrain that was used (129/SvJ vs. 129/SvEv) and the age of the animals used. Although
Belzung, & Barreau also tested mice during adolescence, their mice were at least one week older
than the mice used in our study at the time of drug exposure. Adolescence is a developmental
time period characterized by ongoing brain development, which in humans, may contribute to
novelty seeking and high-risk adolescent behavior (Steinberg, 2007). It is therefore possible that
the adolescent mice used in the current study respond differently to drugs of abuse than the older
mice used in previous work. It is also possible that our results are dependent on the dose of
methamphetamine used and a higher dose might lead to different behavioral results.
There are several potential mechanisms that may account for the sex and strain
differences that we report. One possibility is that methamphetamine triggered a differential
stress response in each group of animals tested, leading to a stronger drug-associated memory in
some groups than others. Indeed, it has been shown that the same dose of methamphetamine
used in our study leads to a longer lasting increase in the stress hormone corticosterone in adult
C57Bl/6 females than males (Zuloaga et al., 2014). Following release by the adrenal glands,
corticosterone is known to activate glucocorticoid receptors located throughout the brain, where
it can function to enhance memory consolidation (Aubry, Serrano, & Burghardt, 2016). It is
therefore possible that the C57Bl/6 females and the 129Sv/Ev males in our study had a relatively
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stronger corticosterone response to methamphetamine than the129/SvEv females and C57Bl/6
males, respectively, and as a result consolidated the drug-associated memory better. This, in
turn, would lead to better retrieval of the drug-associated memory during the postconditioning
session, leading animals to spend more time in the drug-paired compartment. Additional studies
are currently underway to test whether the behavioral responses reported in our study correlate
with differences in methamphetamine-induced plasma corticosterone.
Before any treatment was given, we found that C57Bl/6 and 129/SvEv mice of both sexes
spent more time in the dark compartment than the light compartment. These results are in line
with an earlier report that male C57Bl/6 mice spend most of their time exploring the dark
compartment in the light/dark task, in spite of their tendency to be highly active (Bourin &
Hascoët, 2003; HascoëT, & Bourin,1998). Similarly, mid-adolescent male 129/SvEv mice have
also been reported to spend more time exploring the dark compartment of the light/dark task
(Rodgers, Boullier, Chatzimichalaki, Cooper, & Shorten, 2002). Avoidance of the light
compartment in the light/dark test has been used as a measure of anxiety. Therefore, an increase
in time spent in the light compartment of the CPP box after being associated with
methamphetamine would not only suggest that the drug was rewarding but it may have led to an
attenuation of the initial anxiety-like response.
We found that regardless of sex, 129/SvEv mice but not C57Bl/6 mice display
methamphetamine-induced sensitization, demonstrating a strain difference in the locomotorinducing effects of this drug. These results are similar to a previous study that tested the effects
of repeated administration of cocaine (20 mg/kg) on locomotor activity. They found that both
male 129/J and C57Bl6 mice showed an increase in activity over successive trials, but this
increase was significantly greater in 129/J mice (Zhang, Mantsch, Schlussman, Ho, & Kreek,
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2002), indicating enhanced sensitization in this strain. Behavioral sensitization to
methamphetamine has been attributed to an increase in the extracellular levels of dopamine in
the nucleus accumbens and caudate-putamen (He & Shippenberg, 2000; Zhang, Mantsch,
Schlussman, Ho, & Kreek, 2002), leading to activation of D1 and D2 receptors (Kalivas, &
Stewart, 1991). Therefore, it is possible that the 129/SvEv strain is more sensitive to the
locomotor enhancing effects of methamphetamine because they respond to repeated
administration of this drug with a larger increase in extrasynaptic levels of dopamine, leading to
more binding of the D1 and D2 receptors. Another possibility is that repeated exposure to
methamphetamine alters D1 and D2 receptor density and/or function in this strain. While such
changes could account for the sensitization effect exhibited by both male and female 129/SvEv
mice, they do not account for the sex differences in methamphetamine-induced CPP that we
report. Specifically, our results showing that methamphetamine induced behavioral sensitization
but not CPP in female 129/SvEv mice indicates the existence of nonoverlapping mechanisms
mediating these two behaviors.
Given that the two strains tested in our study are commonly used background strains for
creating transgenic mice, our findings provide insight into which sex and strain might be most
appropriate for future work testing the role of specific proteins in methamphetamine-induced
CPP. For example, if the goal of a study is to test the hypothesis that removal of a specific
protein blocks methamphetamine-induced conditioned place preference, then the females should
be tested if the knockout mouse is on C57Bl/6 background and males should be tested if a
129/SvEv background is used. Alternatively, if the hypothesis is that upregulation of a protein
will enhance conditioned place preference, then it might be easiest to detect this enhancement if
overexpression occurs in animals that do not normally exhibit methamphetamine CPP (i.e.
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females on 129/SvEv background or males on a C57Bl/6 background). Finally, if the goal of a
study is to address mechanisms underlying sex differences in the rewarding effects of
methamphetamine, the C57Bl/6 strain is appropriate, since we found that the females are more
sensitive than the males. Indeed enhanced sensitivity in females mirrors what has been described
in humans. It is hoped that our work will provide the basis of future studies using genetic
techniques to both identify the neural basis of sex differences in drug abuse and investigate
factors that might enhance vulnerability to addiction within a species.
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Figure 1. Mean time (seconds) that female C57Bl/6 (n= 40) and 129/SvEv (n=
40) mice spent in the light and dark compartments during preconditioning; ^p <
0.01 versus C57Bl/6 on light side; *p < 0.01 versus 129/SvEv on light side.
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Figure 2. Locomotor activity of methamphetamine-treated (n=22) and salinetreated (n=23) adolescent female C57Bl/6 mice on the days that mice received
their first (first injection) and last (fourth injection) exposure to
methamphetamine. *p < 0.05 versus saline control after the first injection; ^p <
0.05 versus saline control after the fourth injection.
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Figure 3. Locomotor activity of methamphetamine-treated (n= 16) and salinetreated (n= 16) adolescent female 129/SvEv mice on the days that mice received
their first (first injection) and last (fourth injection) exposure to
methamphetamine. *p < 0.05 versus saline control after the first injection; ^p <
0.01 versus saline control after the fourth injection.
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Figure 4. Locomotor activity of female C57Bl/6 (n =23) and 129/SvEv (n =15)
mice during the first and fourth injection of methamphetamine. Data are
expressed as percent change relative to the corresponding saline-treated control
group, which was set to 100% (dashed line). *p < 0.05 versus C57Bl/6 during 4th
injection of methamphetamine and versus 129/SvEv during 1st injection of
methamphetamine.
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Figure 5. CPP score of adolescent female C57Bl/6 mice following treatment with
methamphetamine (1mg/kg) (n=12) or saline (n=19), *p < 0.05.
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Figure 6. CPP score of adolescent female 129/SvEv mice following treatment with
methamphetamine (1mg/kg) (n= 11) or saline (n= 20).

24

METHAMPHETAMINE-INDUCED CPP

25

Figure 7. Mean time (seconds) that male C57Bl/6 (n =24) and 129/SvEv (n=23) mice spent in
the light and dark compartments, prior to treatment. ^p <0.01 versus C57Bl/6 on light side; *p <
0.05 versus 129/SvEv on light side.
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Figure 8. Locomotor activity of methamphetamine-treated (n= 12) and saline-treated (n=12)
adolescent male C57Bl/6 mice on days that mice received their first (first injection) and last
(fourth injection) exposure to methamphetamine. *p < 0.05 versus saline control after the first
injection; ^p < 0.01 versus saline control after the fourth injection.
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Figure 9.Locomotor activity of methamphetamine-treated (n=12) and saline-treated (n= 12)
adolescent male 129/SvEv on days that mice received their first (first injection) and last (fourth
injection) exposure to methamphetamine. *p < 0.05 versus saline control after the first injection;.
^p < 0.01 versus saline control after the fourth injection.
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Figure 10. Locomotor activity of drug-treated C57Bl/6 (n =12) and 129/SvEv (n =12) male mice
during the first and fourth injection of methamphetamine. Data are expressed as percent change
relative to the corresponding saline-treated control group, which was set to 100% (dashed line).
*p < 0.01 versus C57Bl/6 during the 4th injection of methamphetamine and versus 129/SvEv
during the 1st injection of methamphetamine.

METHAMPHETAMINE-INDUCED CPP

Figure 11. CPP score for adolescent male C57Bl/6 mice following treatment with
methamphetamine (1mg/kg) (n= 12) or saline (n= 12).
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METHAMPHETAMINE-INDUCED CPP

Figure 12. CPP score for adolescent male 129/SvEv mice following treatment with
methamphetamine (1mg/kg) (n= 11) or saline (n= 12). *p < 0.05
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